Stock listing

NASDAQ:RDHL RedHill Biopharma Ltd. Stock

Follow RedHill Biopharma Ltd. into a list and get an email when it puts out news.

Share price · NASDAQ:RDHL

$0.281 USD -0.069 (-19.7%)

Close on Nov 20, 2026

Past year -73.0% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$0.281 – $0.339 USDNov 20, 2026
Volume
24,254 sharesNov 20, 2026
Market cap
$2.50M USDAt the close on Nov 20, 2026 · price × 8.89M shares outstanding
52-week range
$0.281 – $1.600 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$1.72M USDMedian day 89,600 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
RedHill Biopharma Ltd. logo

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:RDHL · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.281-0.069-19.7%$0.311$0.339$0.28124,254
$0.3500.0000.0%$0.350$0.350$0.330139,147
$0.350-0.011-2.9%$0.360$0.375$0.35048,643
$0.361-0.015-3.9%$0.375$0.385$0.36136,685
$0.375-0.006-1.6%$0.370$0.393$0.37035,193
$0.381+0.015+4.1%$0.370$0.400$0.36071,197
$0.366-0.009-2.4%$0.384$0.387$0.36634,250
$0.375-0.020-5.0%$0.395$0.400$0.37557,678
$0.395-0.033-7.7%$0.430$0.440$0.39135,024
$0.428+0.002+0.4%$0.420$0.450$0.42035,363
$0.426+0.004+0.9%$0.440$0.450$0.42043,111
$0.422+0.006+1.5%$0.395$0.422$0.39539,097
$0.416-0.026-5.8%$0.440$0.456$0.41024,168
$0.442+0.054+13.8%$0.390$0.471$0.390313,494
$0.388-0.029-7.0%$0.400$0.410$0.380109,100
$0.417-0.011-2.6%$0.438$0.438$0.39085,000
$0.428-0.020-4.5%$0.445$0.449$0.42214,400
$0.448+0.032+7.7%$0.410$0.449$0.408109,300
$0.416-0.007-1.7%$0.415$0.441$0.390116,200
$0.423+0.001+0.2%$0.410$0.447$0.410108,100
$0.422-0.033-7.3%$0.465$0.468$0.414236,600
$0.455-0.052-10.3%$0.470$0.490$0.455147,200
$0.507+0.006+1.2%$0.483$0.520$0.460125,200
$0.501+0.021+4.4%$0.496$0.515$0.486331,600
$0.480-0.019-3.8%$0.500$0.520$0.48084,900
$0.499+0.013+2.7%$0.487$0.515$0.48359,400
$0.486-0.029-5.6%$0.505$0.510$0.48084,700
$0.515-0.018-3.4%$0.515$0.533$0.50081,600
$0.533-0.006-1.1%$0.543$0.560$0.51370,000
$0.539-0.039-6.7%$0.545$0.592$0.520379,300
$0.578+0.104+21.9%$0.499$0.691$0.43515,754,300
$0.474-0.010-2.1%$0.471$0.496$0.47136,100
$0.484-0.009-1.8%$0.495$0.500$0.47557,900
$0.493-0.007-1.4%$0.500$0.508$0.49090,700
$0.500+0.020+4.2%$0.515$0.515$0.488130,200
$0.4800.0000.0%$0.465$0.492$0.465556,300
$0.480-0.001-0.2%$0.480$0.501$0.479217,900
$0.481-0.025-4.9%$0.491$0.496$0.47592,100
$0.506+0.006+1.2%$0.500$0.519$0.49089,600
$0.500-0.020-3.8%$0.525$0.525$0.500102,900
$0.520-0.023-4.2%$0.543$0.556$0.52089,400
$0.543+0.002+0.4%$0.530$0.550$0.52480,300
$0.541-0.009-1.6%$0.545$0.568$0.520200,700
$0.550-0.018-3.2%$0.560$0.568$0.53977,800
$0.568-0.025-4.2%$0.580$0.590$0.56081,000
$0.593+0.043+7.8%$0.570$0.600$0.570230,800
$0.550-0.025-4.3%$0.570$0.580$0.541217,100
$0.575-0.039-6.4%$0.600$0.600$0.560252,500
$0.614-0.031-4.8%$0.620$0.620$0.590207,100
$0.645-0.008-1.2%$0.655$0.680$0.620265,900
$0.653-0.043-6.2%$0.700$0.700$0.653152,300
$0.696+0.046+7.1%$0.650$0.710$0.650224,400
$0.650-0.074-10.2%$0.717$0.730$0.650400,800
$0.724+0.011+1.5%$0.740$0.769$0.700575,700
$0.713-0.028-3.8%$0.738$0.778$0.702445,300
$0.741-0.129-14.8%$0.844$0.882$0.7211,439,500
$0.870-0.030-3.3%$0.882$0.900$0.7803,825,600
$0.900+0.239+36.2%$1.360$1.600$0.900104,018,900
$0.661+0.031+4.9%$0.635$0.700$0.62042,400
$0.630+0.015+2.4%$0.595$0.630$0.59335,600
$0.615+0.010+1.6%$0.605$0.628$0.60516,500
$0.6050.0000.0%$0.614$0.614$0.6004,997
$0.605-0.025-3.9%$0.638$0.638$0.60211,940
$0.630+0.005+0.8%$0.612$0.650$0.60019,400
$0.625-0.003-0.5%$0.620$0.650$0.62015,300

Splits

2 splits since 2023 · NASDAQ:RDHL · every price before a split is adjusted for it

DayRatioWhat
1-for-25Consolidation
1-for-40Consolidation
Ticker
NASDAQ:RDHL
Asset type
Stock
Exchange
NASDAQ
Currency
USD

What changed lately

Latest news

All RedHill Biopharma Ltd. news

RedHill Biopharma Ltd. on 6ix

News releases
5 in the last 12 months · 5 in all · newest Nov 17, 2026 · oldest 2025
Calls
5 calls with a replay · 5 with a transcript · latest Jun 23, 2022
Decks
13 decks · latest Dec 15, 2022

Valuation

price Nov 20, 2026

Enterprise value
No statements on 6ix yet
P/E
No statements on 6ix yet
EV/sales
No statements on 6ix yet
EV/EBITDA
No statements on 6ix yet
Price/book
No statements on 6ix yet
Gross margin
No statements on 6ix yet
Operating margin
No statements on 6ix yet
Net margin
No statements on 6ix yet
Debt to equity
No statements on 6ix yet
Beta vs S&P 500
0.88

Team and board

Officers

OfficerRole
Abe SchwartzPresident and CEO of Schwartz Technologies Corporation
Dror Ben-AsherChairman & CEO
Razi IngberCFO
Rick D. ScruggsPresident, RedHill Biopharma Inc. & Chief Commercial Officer
Gilead RadayChief Operating Officer
Patricia AndersonSenior VP Regulatory Affairs
Reza FathiSenior VP R&D
Adi FrishChief Corporate & Business Development Officer
Guy GoldbergChief Business Officer
Ira KalfusChief Medical Officer
Mark L. LevittChief Scientific Officer

Board

DirectorRole
Dror Ben-AsherChairman & CEO
Kenneth ReedDirector
Ofer TsimchiDirector
Roni MamlukDirector
Shmuel CabillyDirector

Events

Results days

QuarterResultsShare move
Quarter to Dec 31, 2025Mar 12, 2026−1.0%
Quarter to Sep 30, 2025Dec 2, 2025−5.7%
Quarter to Jun 30, 2025Sep 5, 2025+17.1%
Quarter to Mar 31, 2025Apr 10, 2025−10.7%
Quarter to Dec 31, 2024Mar 31, 2025−8.6%
Quarter to Sep 30, 2024Nov 29, 2024+2.9%
Quarter to Jun 30, 2024Aug 29, 2024 · Before open+3.1%
Quarter to Mar 31, 2024Apr 8, 2024 · Before open−0.9%
Quarter to Dec 31, 2023Feb 12, 2024 · Before open−2.5%
Quarter to Sep 30, 2023Nov 15, 2023−0.7%
All 20 quarters
QuarterResultsShare move
Quarter to Jun 30, 2023Aug 17, 2023 · Before open+13.4%
Quarter to Mar 31, 2023Apr 28, 2023 · Before open+6.6%
Quarter to Dec 31, 2022Mar 27, 2023−0.6%
Quarter to Sep 30, 2022Nov 29, 2022 · Before open−6.1%
Q2 2022Sep 23, 2022 · After close+1.4%
Quarter to Mar 31, 2022Jun 23, 2022 · Before open+0.2%
Quarter to Dec 31, 2021Mar 17, 2022 · Before open+24.6%
Quarter to Sep 30, 2021Nov 30, 2021 · Before open+4.3%
Q2 2021Aug 26, 2021 · Before open+1.5%
Quarter to Mar 31, 2021May 27, 2021 · Before open+1.3%

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (December 2022)Investor deck81 slidesDec 15, 2022
Investor Presentation (October 2022)Investor deck77 slidesOctober 2022
Investor Presentation (June 2022)Investor deck77 slidesJune 2022
Investor Presentation (April 2022)Investor deck77 slidesApr 14, 2022
Q3 2021 Earnings PresentationEarnings46 slidesNov 30, 2021
Technical Presentation (October 2021)Technical25 slidesOct 7, 2021
Investor Presentation (September 2021)Investor deck71 slidesSeptember 2021
IPO Roadshow (March 2021)IPO roadshow35 slidesMar 1, 2021
IPO Roadshow (January 2021)IPO roadshow34 slidesJan 11, 2021
Technical Presentation (October 2018)Technical44 slidesOct 30, 2018
All 13 decks
DeckKindSlidesDate
Investor Day (April 2017)Investor day88 slidesApr 27, 2017
Innovations in Gastroenterology 2017 SymposiumConference21 slidesJan 4, 2017
IPO Roadshow (November 2016)IPO roadshow65 slidesNov 1, 2016

Open Decks

Financials

Annual, in USD

Income statement

LineFY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
Revenue8.04M6.53M61.8M85.8M64.4M6.29M8.36M4.01M101.0K3.00K
Cost of revenue3.19M3.46M33.3M49.4M36.9M2.26M2.84M2.13M
Gross profit4.85M3.07M28.5M36.4M27.5M4.03M5.52M1.88M101.0K3.00K
Research and development1.59M3.53M7.28M29.5M16.5M17.4M24.9M33.0M25.2M17.8M
Selling, general and administrative9.57M16.2M28.6M32.4M25.4M11.5M7.51M8.03M3.85M2.75M
Operating income-14.6M12.6M-42.8M-81.1M-63.7M-43.2M-39.3M-52.0M-30.5M-22.0M
Depreciation and amortization588.0K1.45M2.14M1.91M1.71M997.0K90.0K81.0K44.0K36.0K
EBITDA-14.0M14.1M-40.7M-79.2M-62.0M-42.2M-39.2M-51.9M-30.5M-22.0M
Interest expense2.06M9.61M42.4M16.7M12.8M438.0K167.0K77.0K375.0K212.0K
Net income-8.27M23.9M-71.7M-97.7M-76.2M-42.3M-38.8M-45.5M-29.4M-21.1M
Earnings per share, basic0.000.01-0.12-0.21-0.21-0.14-0.17-0.26-0.23-0.19
Earnings per share, diluted0.000.01-0.12-0.21-0.21-0.14-0.17-0.26-0.24-0.19

Balance sheet

LineFY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
Cash and equivalents4.62M5.57M20.0M29.5M29.3M29.0M29.0M16.5M53.8M21.5M
Receivables2.54M2.59M34.5M31.7M28.7M1.22M958.0K1.53M99.0K
Inventory3.65M4.39M11.0M14.8M6.53M1.88M769.0K653.0K
Current assets11.9M16.1M85.9M89.2M70.5M53.2M56.8M51.7M67.8M
Property, plant and equipment135.0K193.0K502.0K572.0K511.0K228.0K163.0K230.0K165.0K
Total assets18.0M23.0M158.9M181.2M180.2M74.1M62.4M57.3M74.2M
Accounts payable1.17M3.28M4.23M11.7M11.6M4.18M3.32M4.80M60.0K
Current liabilities22.2M20.0M197.5M81.5M73.2M10.6M10.4M11.8M5.36M
Long-term debt83.6M81.4M
Total debt83.6M81.4M
Total liabilities22.7M21.0M207.3M172.3M166.4M14.1M11.2M12.3M11.5M
Shareholders' equity-4.68M2.07M-48.4M8.88M13.9M60.0M51.2M45.1M62.7M60.1M

Cash flow

LineFY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
Cash from operations-9.37M-35.8M-29.2M-65.0M-48.6M-40.7M-34.5M-44.8M-28.3M-17.8M
Capital spending-9.00K-11.0K-198.0K-115.0K-406.0K-168.0K-23.0K-146.0K-85.0K-14.0K
Free cash flow-9.38M-35.8M-29.4M-65.2M-49.0M-40.9M-34.5M-44.9M-28.3M-17.8M
Cash from investing-9.00K4.00K8.30M-8.14M-35.6M5.16M5.35M-18.6M24.5M-21.2M
Cash from financing8.42M21.4M11.5M73.5M84.4M35.5M41.8M25.7M36.0M54.8M
Change in cash-961.0K-14.4M-9.43M275.0K142.0K-76.0K12.7M-37.7M32.2M15.8M

Open Financials

Filings

FilingDateTypeFiled with
6-K · Report of a foreign issuerNov 2, 2026Current reportSEC
6-K · Report of a foreign issuerOct 21, 2026Current reportSEC
6-K · Report of a foreign issuerOct 19, 2026Current reportSEC
6-K · Report of a foreign issuerOct 13, 2026Current reportSEC
424B5 · ProspectusOct 13, 2026Offer documentSEC
6-K · Report of a foreign issuerOct 7, 2026Current reportSEC
4 · Change in ownershipOct 6, 2026Insider tradeSEC
6-K · Report of a foreign issuerSep 30, 2026Current reportSEC
6-K · Report of a foreign issuerSep 30, 2026Current reportSEC
6-K · Report of a foreign issuerSep 1, 2026Current reportSEC
Show 200 filings
FilingDateTypeFiled with
6-K · Report of a foreign issuerAug 31, 2026Current reportSEC
6-K · Report of a foreign issuerAug 7, 2026Current reportSEC
6-K · Report of a foreign issuerAug 6, 2026Current reportSEC
6-K · Report of a foreign issuerJul 28, 2026Current reportSEC
424B3 · ProspectusJul 14, 2026Offer documentSEC
EFFECT · Notice that a registration is effectiveJul 14, 2026Other filingsSEC
4 · Change in ownershipJul 13, 2026Insider tradeSEC
F-3 · Registration statementJul 2, 2026Offer documentSEC
6-K · Report of a foreign issuerJul 1, 2026Current reportSEC
6-K · Report of a foreign issuerJun 29, 2026Current reportSEC
424B5 · ProspectusJun 29, 2026Offer documentSEC
6-K · Report of a foreign issuerJun 25, 2026Current reportSEC
6-K · Report of a foreign issuerJun 22, 2026Current reportSEC
6-K · Report of a foreign issuerJun 22, 2026Current reportSEC
6-K · Report of a foreign issuerJun 22, 2026Current reportSEC
6-K · Report of a foreign issuerJun 18, 2026Current reportSEC
6-K · Report of a foreign issuerJun 9, 2026Current reportSEC
6-K · Report of a foreign issuerJun 8, 2026Current reportSEC
6-K · Report of a foreign issuerJun 2, 2026Current reportSEC
6-K · Report of a foreign issuerMay 27, 2026Current reportSEC
424B5 · ProspectusMay 7, 2026Offer documentSEC
EFFECT · Notice that a registration is effectiveMay 6, 2026Other filingsSEC
POS AM · Amendment to an effective registrationMay 4, 2026Offer documentSEC
6-K · Report of a foreign issuerApr 30, 2026Current reportSEC
20-F · Annual reportApr 27, 2026Annual reportSEC
6-K · Report of a foreign issuerApr 27, 2026Current reportSEC
4 · Change in ownershipApr 22, 2026Insider tradeSEC
6-K · Report of a foreign issuerApr 22, 2026Current reportSEC
6-K · Report of a foreign issuerApr 14, 2026Current reportSEC
3 · Initial statement of ownershipMar 19, 2026Insider tradeSEC
3 · Initial statement of ownershipMar 18, 2026Insider tradeSEC
3 · Initial statement of ownershipMar 18, 2026Insider tradeSEC
3 · Initial statement of ownershipMar 18, 2026Insider tradeSEC
3 · Initial statement of ownershipMar 18, 2026Insider tradeSEC
3 · Initial statement of ownershipMar 18, 2026Insider tradeSEC
3 · Initial statement of ownershipMar 18, 2026Insider tradeSEC
3 · Initial statement of ownershipMar 18, 2026Insider tradeSEC
3 · Initial statement of ownershipMar 18, 2026Insider tradeSEC
3 · Initial statement of ownershipMar 18, 2026Insider tradeSEC
6-K · Report of a foreign issuerMar 5, 2026Current reportSEC
6-K · Report of a foreign issuerFeb 25, 2026Current reportSEC
424B3 · ProspectusFeb 2, 2026Offer documentSEC
EFFECT · Notice that a registration is effectiveJan 28, 2026Other filingsSEC
6-K · Report of a foreign issuerJan 27, 2026Current reportSEC
CORRESP · Letter to the SECJan 26, 2026Other filingsSEC
S-8 · Registration statement for employee plansJan 22, 2026Offer documentSEC
F-1/A · Registration statement, amendedJan 22, 2026Offer documentSEC
6-K · Report of a foreign issuerJan 22, 2026Current reportSEC
UPLOAD · Letter from the SECJan 6, 2026Other filingsSEC
6-K · Report of a foreign issuerJan 5, 2026Current reportSEC
F-1 · Registration statementDec 31, 2025Offer documentSEC
6-K · Report of a foreign issuerDec 31, 2025Current reportSEC
SCHEDULE 13G · Big-stake noticeDec 23, 2025Big-stake noticeSEC
6-K · Report of a foreign issuerDec 23, 2025Current reportSEC
6-K · Report of a foreign issuerDec 15, 2025Current reportSEC
6-K · Report of a foreign issuerDec 1, 2025Current reportSEC
6-K · Report of a foreign issuerNov 26, 2025Current reportSEC
424B5 · ProspectusNov 26, 2025Offer documentSEC
6-K · Report of a foreign issuerNov 4, 2025Current reportSEC
6-K · Report of a foreign issuerOct 22, 2025Current reportSEC
424B3 · ProspectusOct 21, 2025Offer documentSEC
6-K · Report of a foreign issuerOct 21, 2025Current reportSEC
SCHEDULE 13G · Big-stake noticeOct 20, 2025Big-stake noticeSEC
6-K · Report of a foreign issuerOct 20, 2025Current reportSEC
6-K · Report of a foreign issuerOct 6, 2025Current reportSEC
6-K · Report of a foreign issuerSep 29, 2025Current reportSEC
EFFECT · Notice that a registration is effectiveSep 10, 2025Other filingsSEC
EFFECT · Notice that a registration is effectiveSep 10, 2025Other filingsSEC
POS AM · Amendment to an effective registrationSep 5, 2025Offer documentSEC
POS AM · Amendment to an effective registrationSep 5, 2025Offer documentSEC
6-K/A · Report of a foreign issuer, amendedSep 5, 2025Current reportSEC
6-K · Report of a foreign issuerSep 5, 2025Current reportSEC
6-K · Report of a foreign issuerAug 20, 2025Current reportSEC
6-K · Report of a foreign issuerAug 18, 2025Current reportSEC
6-K · Report of a foreign issuerAug 14, 2025Current reportSEC
6-K · Report of a foreign issuerJul 21, 2025Current reportSEC
EFFECT · Notice that a registration is effectiveJul 3, 2025Other filingsSEC
424B3 · ProspectusJul 2, 2025Offer documentSEC
6-K · Report of a foreign issuerJul 1, 2025Current reportSEC
CORRESP · Letter to the SECJun 30, 2025Other filingsSEC
UPLOAD · Letter from the SECJun 30, 2025Other filingsSEC
F-1 · Registration statementJun 25, 2025Offer documentSEC
6-K · Report of a foreign issuerJun 25, 2025Current reportSEC
6-K · Report of a foreign issuerMay 27, 2025Current reportSEC
6-K · Report of a foreign issuerMay 19, 2025Current reportSEC
6-K · Report of a foreign issuerMay 13, 2025Current reportSEC
6-K · Report of a foreign issuerMay 5, 2025Current reportSEC
6-K · Report of a foreign issuerMay 2, 2025Current reportSEC
6-K · Report of a foreign issuerApr 28, 2025Current reportSEC
6-K · Report of a foreign issuerApr 17, 2025Current reportSEC
6-K · Report of a foreign issuerApr 16, 2025Current reportSEC
6-K · Report of a foreign issuerApr 10, 2025Current reportSEC
20-F · Annual reportApr 10, 2025Annual reportSEC
6-K · Report of a foreign issuerApr 8, 2025Current reportSEC
6-K · Report of a foreign issuerApr 1, 2025Current reportSEC
6-K · Report of a foreign issuerMar 26, 2025Current reportSEC
S-8 · Registration statement for employee plansMar 25, 2025Offer documentSEC
6-K · Report of a foreign issuerMar 18, 2025Current reportSEC
6-K · Report of a foreign issuerMar 12, 2025Current reportSEC
6-K · Report of a foreign issuerFeb 27, 2025Current reportSEC
6-K · Report of a foreign issuerFeb 25, 2025Current reportSEC
6-K · Report of a foreign issuerFeb 4, 2025Current reportSEC
6-K · Report of a foreign issuerFeb 3, 2025Current reportSEC
424B5 · ProspectusFeb 3, 2025Offer documentSEC
6-K · Report of a foreign issuerJan 21, 2025Current reportSEC
6-K · Report of a foreign issuerDec 10, 2024Current reportSEC
6-K · Report of a foreign issuerDec 2, 2024Current reportSEC
SC 13G/A · Big-stake notice, amendedNov 14, 2024Big-stake noticeSEC
6-K · Report of a foreign issuerOct 28, 2024Current reportSEC
6-K · Report of a foreign issuerOct 22, 2024Current reportSEC
6-K · Report of a foreign issuerOct 15, 2024Current reportSEC
6-K · Report of a foreign issuerOct 1, 2024Current reportSEC
6-K · Report of a foreign issuerSep 30, 2024Current reportSEC
6-K · Report of a foreign issuerSep 18, 2024Current reportSEC
6-K · Report of a foreign issuerSep 17, 2024Current reportSEC
6-K · Report of a foreign issuerSep 9, 2024Current reportSEC
6-K · Report of a foreign issuerSep 5, 2024Current reportSEC
6-K · Report of a foreign issuerSep 5, 2024Current reportSEC
6-K · Report of a foreign issuerSep 3, 2024Current reportSEC
6-K · Report of a foreign issuerAug 29, 2024Current reportSEC
6-K · Report of a foreign issuerAug 26, 2024Current reportSEC
6-K · Report of a foreign issuerAug 21, 2024Current reportSEC
EFFECT · Notice that a registration is effectiveAug 20, 2024Other filingsSEC
6-K · Report of a foreign issuerAug 19, 2024Current reportSEC
6-K · Report of a foreign issuerAug 16, 2024Current reportSEC
CORRESP · Letter to the SECAug 15, 2024Other filingsSEC
UPLOAD · Letter from the SECAug 15, 2024Other filingsSEC
424B3 · ProspectusAug 13, 2024Offer documentSEC
6-K · Report of a foreign issuerAug 13, 2024Current reportSEC
F-3 · Registration statementAug 9, 2024Offer documentSEC
SCHEDULE 13D · Big-stake noticeAug 7, 2024Big-stake noticeSEC
424B3 · ProspectusAug 7, 2024Offer documentSEC
6-K · Report of a foreign issuerAug 6, 2024Current reportSEC
6-K · Report of a foreign issuerAug 1, 2024Current reportSEC
6-K · Report of a foreign issuerJul 22, 2024Current reportSEC
6-K · Report of a foreign issuerJul 9, 2024Current reportSEC
S-8 · Registration statement for employee plansJun 20, 2024Offer documentSEC
6-K · Report of a foreign issuerJun 6, 2024Current reportSEC
6-K · Report of a foreign issuerJun 3, 2024Current reportSEC
6-K · Report of a foreign issuerMay 6, 2024Current reportSEC
6-K · Report of a foreign issuerApr 24, 2024Current reportSEC
EFFECT · Notice that a registration is effectiveApr 23, 2024Other filingsSEC
POS AM · Amendment to an effective registrationApr 18, 2024Offer documentSEC
6-K · Report of a foreign issuerApr 8, 2024Current reportSEC
20-F · Annual reportApr 8, 2024Annual reportSEC
6-K · Report of a foreign issuerApr 4, 2024Current reportSEC
6-K · Report of a foreign issuerApr 3, 2024Current reportSEC
424B5 · ProspectusApr 2, 2024Offer documentSEC
6-K · Report of a foreign issuerApr 2, 2024Current reportSEC
6-K · Report of a foreign issuerMar 21, 2024Current reportSEC
6-K · Report of a foreign issuerMar 20, 2024Current reportSEC
6-K · Report of a foreign issuerMar 14, 2024Current reportSEC
6-K · Report of a foreign issuerMar 11, 2024Current reportSEC
6-K · Report of a foreign issuerMar 5, 2024Current reportSEC
6-K · Report of a foreign issuerFeb 20, 2024Current reportSEC
6-K · Report of a foreign issuerFeb 20, 2024Current reportSEC
424B3 · ProspectusFeb 16, 2024Offer documentSEC
EFFECT · Notice that a registration is effectiveFeb 16, 2024Other filingsSEC
CORRESP · Letter to the SECFeb 15, 2024Other filingsSEC
UPLOAD · Letter from the SECFeb 14, 2024Other filingsSEC
6-K · Report of a foreign issuerFeb 13, 2024Current reportSEC
F-1 · Registration statementFeb 9, 2024Offer documentSEC
DFeb 5, 2024Other filingsSEC
SC 13G · Big-stake noticeFeb 2, 2024Big-stake noticeSEC
SC 13G · Big-stake noticeFeb 1, 2024Big-stake noticeSEC
6-K · Report of a foreign issuerJan 26, 2024Current reportSEC
6-K · Report of a foreign issuerJan 26, 2024Current reportSEC
424B5 · ProspectusJan 26, 2024Offer documentSEC
6-K · Report of a foreign issuerJan 25, 2024Current reportSEC
6-K · Report of a foreign issuerJan 25, 2024Current reportSEC
SC 13G/A · Big-stake notice, amendedJan 8, 2024Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedJan 2, 2024Big-stake noticeSEC
6-K · Report of a foreign issuerDec 20, 2023Current reportSEC
6-K · Report of a foreign issuerDec 12, 2023Current reportSEC
6-K · Report of a foreign issuerDec 6, 2023Current reportSEC
6-K · Report of a foreign issuerDec 4, 2023Current reportSEC
6-K · Report of a foreign issuerDec 1, 2023Current reportSEC
6-K · Report of a foreign issuerNov 27, 2023Current reportSEC
6-K · Report of a foreign issuerNov 16, 2023Current reportSEC
6-K · Report of a foreign issuerNov 14, 2023Current reportSEC
EFFECT · Notice that a registration is effectiveOct 27, 2023Other filingsSEC
424B3 · ProspectusOct 26, 2023Offer documentSEC
CORRESP · Letter to the SECOct 26, 2023Other filingsSEC
F-3/A · Registration statement, amendedOct 23, 2023Offer documentSEC
6-K · Report of a foreign issuerOct 16, 2023Current reportSEC
F-3 · Registration statementOct 13, 2023Offer documentSEC
DOct 12, 2023Other filingsSEC
6-K · Report of a foreign issuerOct 10, 2023Current reportSEC
6-K · Report of a foreign issuerOct 3, 2023Current reportSEC
6-K · Report of a foreign issuerSep 29, 2023Current reportSEC

This page holds 200 of 1,000 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from RedHill Biopharma Ltd.’s releases

Common shares
8,887,684
Fully diluted
8,887,684

Fully diluted

LineShares
Common shares8,887,684

Share count over time

CountShares
Nov 22, 20268,887,684

Open Cap table

Shareholders

HolderSharesOf the companyValueAs of
Armistice Capital, LLC162K1.8%US$77,829Sep 30, 2026
Citadel106K1.2%US$51,072Sep 30, 2026
Gagnon Securities LLC88,4050.99%US$42,434Sep 30, 2026
Citigroup Inc12,7910.14%US$6,140Sep 30, 2026
Rhumbline Advisers12,1580.14%US$5,834Sep 30, 2026
XTX Topco Ltd10,3620.12%US$4,974Sep 30, 2026
Jane Street10,0840.11%US$4,840Sep 30, 2026
UBS4,9220.06%US$2,363Sep 30, 2026
Federation des caisses Desjardins du Quebec1,9100.02%US$917Sep 30, 2026
RBC351<0.01%Sep 30, 2026
All 15 holders
HolderSharesOf the companyValueAs of
Morgan Stanley306<0.01%US$147Sep 30, 2026
BNP Paribas300<0.01%US$144Sep 30, 2026
SBI Securities Co., Ltd.21<0.01%US$10Sep 30, 2026
Smartleaf Asset Management LLC5<0.01%US$2Sep 30, 2026
JPMorgan4<0.01%US$2Sep 30, 2026

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Roni Mamluk
Other companies: Ayala Pharmaceuticals Inc (President & CEO, Director · May 7, 2020 – Jan 19, 2023 · Past); Chiasma Inc (Director · Jul 15, 2015 – Aug 5, 2021 · Past)
Director · Since at least Mar 18, 2026
Abe SchwartzPresident and CEO of Schwartz Technologies Corporation · Since at least Nov 4, 2026
Adi FrishChief Corporate & Business Development Officer · Since at least Dec 1, 2025
Dror Ben-AsherChairman & CEO · Since at least Mar 18, 2026
Gilead RadayChief Operating Officer · Since at least Mar 18, 2026
Guy GoldbergChief Business Officer · Since at least Mar 18, 2026
Ira KalfusChief Medical Officer · Since at least Nov 4, 2026
Kenneth ReedDirector · Since at least Nov 5, 2026
Mark L. LevittChief Scientific Officer · Since at least Oct 19, 2026
Ofer TsimchiDirector · Since at least Mar 18, 2026
All 15 people
PersonSeat
Patricia AndersonSenior VP Regulatory Affairs · Since at least Nov 5, 2026
Razi IngberCFO · Since at least Mar 18, 2026
Reza FathiSenior VP R&D · Since at least Nov 5, 2026
Rick D. ScruggsPresident, RedHill Biopharma Inc. & Chief Commercial Officer · Since at least Nov 4, 2026
Shmuel CabillyDirector · Since at least Mar 18, 2026

Open People

Log in to ask 6ix AI your own questions about RedHill Biopharma Ltd.